TOPLINE: Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. METHODOLOGY: Researchers conducted a randomized, […]

TOPLINE: Among individuals using HIV pre-exposure prophylaxis (HIV PrEP), doxycycline post-exposure prophylaxis (doxyPEP) is associated with a substantial decline in chlamydia and syphilis incidence. METHODOLOGY: Researchers […]

TOPLINE: Lineages involved in transmission bursts of HIV contribute to nearly three times more future transmission events than those not involved in bursts. Adolescents, gender minorities, […]